RSSCategory: Government

Young Survival Coalition Expresses Concern About Overlooked Moonshot Recommedations

| September 30, 2016 | 0 Comments

I haven’t written much about the President’s Cancer Moonshot initiative recently and as much as I would like – perhaps because following some Blue Ribbon Panel recommendations and a large number of organizations and individuals expressing, in general, positive feedback among the cancer community, there hasn’t been a lot of news about next steps.  I […]

Continue Reading

Dismissiveness of “Pinktober” Starting Early

| September 9, 2016 | 0 Comments

Last Fall I wrote a couple of posts about the growing disenchantment with ‘Pinkification’ and ‘Pinktober’ referencing the all-out blitz during October to go “Pink” for breast bancer awareness and prevention.  In one of the pieces I mentioned by disenchantment with what happened a number of years ago I saw in clinical practice and last […]

Continue Reading

Pathology 2.0 Comes of Age: Recommendations for Protecting Privacy While Motivating Education

| August 10, 2016 | 0 Comments

There is an interesting article in this month’s AMA Journal of Ethics by Drs. Crane and Gardner on the use of pathology images in social media. The authors introduce the article in their abstract as “There is a rising interest in the use of social media by pathologists. However, the use of pathology images on […]

Continue Reading

Beauty Queen Fakes Cancer Diagnosis

| August 9, 2016 | 0 Comments

Courtesy of The Washington Post: Brandi Lee Weaver-Gates does not have cancer. The 24-year-old former beauty queen never has, nor has she ever undergone the agonizing trials of chemotherapy. She has never shivered in a hospital room, awaiting her prognosis. She has never been forced to wonder if she would live another year. With that in mind, […]

Continue Reading

Proposed Medicare 2017 Reimbursement Schedule Whacks Biopsy Payments; Digital Pathology Payments Up

| July 20, 2016 | 3 Comments

The bread and butter of every surgical pathologist, the 88305 biopsy code, among others for larger specimens, face a significant reduction for technical cost reimbursement.  The professional reimbursements are expected to change very little. The proposed reimbursement for an 88305 of under $3o I believe is getting close to what it may cost many labs […]

Continue Reading

Vice President Biden Addresses Attendees at ASCO 2016

| June 7, 2016 | 0 Comments

“This is good news in the fight against cancer. With the launch of this new national resource, anyone can freely access raw genomic and clinical data for 12,000 patients – with more records to follow. Increasing the pool of researchers who can access data and decreasing the time it takes for them to review and […]

Continue Reading

FDA Approves First Liquid Biopsy Test for Use in Non-Small Cell Lung Cancer

| June 1, 2016 | 0 Comments

Exciting news today from FDA with news of approval of first liquid biopsy test for use in non-small cell lung cancer.  The cobas EGFR test is already approved for use in formalin-fixed paraffin-embedded (FFPE) tissue. This new use is intended for detection of these specific mutations in circulating-free tumor DNA (cfDNA) from plasma for first […]

Continue Reading

VP Joe Biden to Speak at ASCO 2016 Special Session

| June 1, 2016 | 0 Comments

Curious to see how 30,000 practicing oncologists react to this and what the level of interest will be in what the VP has to say.  My general sense over these past few months among oncologists is a fair amount of skepticism to the initiative with specific regards to how data is shared and exchanged in […]

Continue Reading

Mayo Clinic Awarded Funding to Support World’s Largest Research-Cohort Biobank

| May 27, 2016 | 0 Comments

As part of President Obama’s Precision Medicine Initiative (PMI), the National Institutes of Health will award $142 million over five years to the Mayo Clinic, Rochester, Minnesota, to establish the world’s largest research-cohort biobank for the PMI Cohort Program, a longitudinal research study which aims to enroll 1 million or more U.S. participants to advance precision medicine. […]

Continue Reading

FDA Technical Guidance Document Does Not Go Far Enough

| May 13, 2016 | 0 Comments

As many readers are aware, on April 20th the FDA released its Technical Guidance Document for Digital Pathology Whole Slide Imaging Devices after draft proposal/review from February of last year. Given its title, this is a technical document, obviously. However, in my opinion, the document, beginning with draft to this finished product, I am sure despite comments to […]

Continue Reading

FDA’s Technical Performance Assessment of Digital Pathology Whole Slide Imaging Devices

| May 10, 2016 | 0 Comments

WHAT DOES IT MEAN TO ME? The Digital Pathology Association 2016 Webinar Series – Session 2 Available to Members Only Thursday, May 25, 2016 | 1pm EST Learn more about the newly released FDA Guidance for Technical Performance Assessment of Digital Pathology Whole Slide Imaging Devices. What does it mean to you? Members of the DPA […]

Continue Reading

The Dark Side of The Moon

With all due respect to Pink Floyd, it seems there is some growing concern the National Cancer Moonshot Initiative is running off course a bit with its recent selection of the “Blue Ribbon Panel” and who is at the table for high level discussions concerning this initiative.  I made some remarks to this in a recent […]

Continue Reading

$40 Pathology Report Reads and Understanding Your Pathology Report

| April 27, 2016 | 0 Comments

Every once in awhile something hits my Facebook feed that makes me wonder how it got there and who means what by it. Beyond the family updates, births, deaths, marriages, divorces, Cubs and Blackhawk updates most recently, I saw one for “Find Out What All Those Numbers Mean – Pathology Reports”. The post (and the […]

Continue Reading

Cancer News in the News Summary

| April 23, 2016 | 0 Comments

Lot going on in cancer care, data mining, cancer immunotherapy funding last week I thought worth sharing.  Clinical pathways, moonshot, data warehousing/mining, IT, immunotherapy to be key words in cancer care, treatment and research for the foreseeable future.  Is all of this activity helping or hurting large scale collaborations? Are ACS and ASCO talking with each other […]

Continue Reading